Ask AI
ProCE Banner Series

Biomarker-Driven Treatment Strategies in High-Grade Glioma

There are rare and invariably lethal high-grade gliomas that carry a poor prognosis and long presented a significant and persistent treatment challenge. How these tumors are identified and characterized has direct implications for how patients are managed. This case-based program examines the diagnostic and treatment landscape in high-grade glioma and considers how a precise diagnostic approach can inform real-world clinical decision-making. Join your multidisciplinary oncology colleagues for a practical look at how a prompt and comprehensive diagnosis can help guide care.

Key Takeaways

  • Discuss the 2021 WHO Guidelines and underscore the need for molecularly confirmed diagnosis in high-grade glioma
  • Define pathophysiology and key biological and diagnostic features of high-grade gliomas
  • Review treatment strategies for patients diagnosed with high-grade gliomas
  • Explore a real patient case and their journey from diagnosis to treatment

All Events

Biomarker-Driven Treatment Strategies in High-Grade Glioma

Upcoming Events

August

20

2026

12:15 PM - 1:15 PM Pacific Time (PT)

Virtual

Acknowledgement

Sponsored By

This webinar is sponsored by Jazz Pharmaceuticals. It is not eligible for Continuing Medical Education (CME) credits.

Jazz Pharmaceuticals